|
Market Closed -
NYSE
01:30:00 28/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.030 USD | +3.32% |
|
+5.90% | -38.32% |
| 01/10 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Stock exchange
NYSE
LCTX 1.030 $
+3.32%
12.32L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LCTX | 1.030USD | +3.32% | 12.32L $ | ||
CBOE
| LCTX | 1.035USD | +3.54% | 20.66T $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 308.10ILa | +0.39% | 4L ILa | |
|
Tradegate
| BT3 | 0.9500EUR | +2.15% | 28.5 € | |
|
Deutsche Boerse AG
| BT3 | 0.9050EUR | +3.78% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9050EUR | -0.22% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.9500EUR | +1.82% | 0 € |
Quotes 5-day view: Lineage Cell Therapeutics, Inc.
Delayed Quote NYSE
| 21/10/2026 | 22/10/2026 | 23/10/2026 | 26/10/2026 | 27/10/2026 | |
|---|---|---|---|---|---|
| Last | $0.9515 | $0.9850 | $1.000 | $0.9969 | $1.030 |
| Volume | 12,20,810 | 13,46,738 | 11,50,709 | 19,08,142 | 11,96,392 |
| Change | -2.17% | +3.52% | +1.52% | -0.31% | +3.32% |
| Opening | $0.9865 | $0.9483 | $0.9657 | $1.000 | $0.9925 |
| High | $0.9903 | $1.010 | $1.015 | $1.010 | $1.040 |
| Low | $0.9376 | $0.9401 | $0.9436 | $0.9616 | $0.9751 |
Performance
| 1 day | +3.32% | ||
| 1 week | +5.90% | ||
| Current month | +7.77% | ||
| 6 months | -33.55% | ||
| Current year | -38.32% | ||
| 1 year | -41.14% | ||
| 3 years | -8.85% | ||
| 5 years | -55.02% | ||
| 10 years | -69.07% |
Volumes
marketsDaily volume
11,96,392
Estimated daily volume
11,96,392
Avg. Volume 20 sessions
14,82,213
Daily volume ratio
0.81
Avg. Volume 20 sessions USD
15,26,679.39
Record volume 1
2,36,61,485
Record volume 2
2,25,39,712
Record volume 3
1,74,30,494
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
26,04,94,687
Net sales (USD)
1,45,56,000
Number of employees
75
Sales / Employee (USD)
1,94,080
Free-Float
95.14%
Free-Float capitalization (USD)
24,78,34,604
Average Daily Capital Traded
0.59%
Indicators
Moving average 5 days
0.9927
Moving average 20 days
0.9591
Moving average 50 days
1.02
Moving average 100 days
1.103
Price spread / (MMA5)
-3.62%
Price spread / (MMA20)
-6.88%
Price spread / (MMA50)
-0.96%
Price spread / (MMA100)
+7.12%
STIM
RSI 9 days
55.32
RSI 14 days
51.78
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.32% | +5.90% | -41.14% | -8.85% | 26Cr | |
| -3.10% | -4.19% | +32.67% | +59.47% | 6.35TCr | |
| +1.53% | +1.07% | +11.59% | +81.76% | 5.45TCr | |
| -0.96% | +1.25% | +10.73% | +102.70% | 5.36TCr | |
| -0.75% | +1.38% | +24.89% | +50.91% | 4.48TCr | |
| -1.30% | -4.80% | +16.05% | +114.76% | 4.16TCr | |
| +1.26% | -5.26% | +221.12% | +900.64% | 3.99TCr | |
| -0.74% | -4.46% | +11.00% | +44.65% | 3.25TCr | |
| +0.47% | +14.73% | +60.96% | +50.98% | 2.67TCr | |
| +3.72% | -6.23% | +26.01% | -8.28% | 2.34TCr | |
| Average | +0.35% | -0.48% | +37.39% | +138.87% | 3.81TCr | |
| Weighted average by Cap. | -0.33% | -1.27% | +43.27% | +155.91% |
Historical Quotes: Lineage Cell Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
a60b5ee259.adbHz_qLsN9X_RVYVWR8_HRtkw3YY3cpqDOYnMpxRhE.W4a3io_C2otvt1gubScsqDoi3kCNLBZ8_ljR14c3B0JZg5a3s9qDkSCTUA
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:30:00 am | 1.030 | 1,56,309 | 11,31,820 |
| 01:29:59 am | 1.035 | 200 | 9,75,511 |
| 01:29:59 am | 1.035 | 137 | 9,75,311 |
| 01:29:58 am | 1.035 | 100 | 9,75,174 |
| 01:29:58 am | 1.035 | 100 | 9,75,074 |
| 01:29:57 am | 1.035 | 114 | 9,74,974 |
| 01:29:57 am | 1.035 | 200 | 9,74,860 |
| 01:29:57 am | 1.035 | 200 | 9,74,660 |
| 01:29:57 am | 1.035 | 386 | 9,74,460 |
| 01:29:57 am | 1.030 | 351 | 9,74,074 |
Price Extremes
| 1 week | 0.94 |  | 1.04 |
| 1 month | 0.88 | | 1.04 |
| Current year | 0.88 | | 1.98 |
| 1 year | 0.88 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.96 |
Monthly variations
Annual variations
| 2026 | -38.32% | ||
| 2025 | +232.34% | ||
| 2024 | -53.90% | ||
| 2023 | -6.84% | ||
| 2022 | -52.24% | ||
| 2021 | +39.20% | ||
| 2020 | +97.75% | ||
| 2019 | -2.52% | ||
| 2018 | -57.53% | ||
| 2017 | -40.44% | ||
| 2016 | -11.95% | ||
| 2015 | +9.92% | ||
| 2014 | +3.61% | ||
| 2013 | +14.65% | ||
| 2012 | -45.96% | ||
| 2011 | -30.25% | ||
| 2010 | +96.93% | ||
| 2009 | +138.98% | ||
| 2008 | +331.71% | ||
| 2007 | +54.72% | ||
| 2006 | -14.52% | ||
| 2005 | -79.47% | ||
| 2004 | +9.42% | ||
| 2003 | -10.97% | ||
| 2002 | -66.30% | ||
| 2001 | -38.67% | ||
| 2000 | -15.49% | ||
| 1999 | -48.92% | ||
| 1998 | -8.55% | ||
| 1997 | +103.57% | ||
| 1996 | +796.00% | ||
| 1995 | +56.25% | ||
| 1994 | -74.60% | ||
| 1993 | -19.23% | ||
| 1992 | -4.88% |
- Stock Market
- Stocks
- LCTX Stock
- Quotes Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
